Catalyst Funds Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-31,741	Closed	-$154K	–	515
2025 Q1	$154K	Buy	+31,741	New	+$154K	0.04%	365
2024 Q4	–	Sell	-10,400	Closed	-$86.8K	–	604
2024 Q3	$86.8K	Hold	10,400	–	–	0.02%	545
2024 Q2	$70.9K	Buy	+10,400	New	+$70.9K	0.02%	353